SWHR Comments on FDA Draft Guidance on Post-Approval Pregnancy Safety Studies Posted on July 8, 2019 by Emily Ortman - Resource
SWHR Provides Input on ICER Value Assessment Framework Posted on June 10, 2019 by Melissa Laitner - Resource
SWHR Expresses Concerns About CMS Guidance for Next Generation Sequencing Posted on January 31, 2019 by Melissa Laitner - Resource
SWHR Encourages Inclusion of Women’s Voices in Patient-Focused Drug Development Posted on December 14, 2018 by Melissa Laitner - Resource
SWHR Expresses Concerns Regarding CMS Step Therapy Proposal Posted on October 5, 2018 by Melissa Laitner - Resource
SWHR Comments on FDA Guidance on Pregnant Women in Clinical Trials Posted on August 8, 2018 by Melissa Laitner - Resource
SWHR Letter on Prioritization of Diagnostic Reform Posted on August 8, 2018 by Melissa Laitner - Resource
SWHR Calls for Oversight on Clinical Laboratory Diagnostics Posted on May 9, 2018 by Melissa Laitner - Resource
SWHR Contributes to Patient-Focused Drug Development Workshop Posted on February 16, 2018 by Melissa Laitner - Resource
